Amicus Therapeutics Inc (NASDAQ:FOLD), a biotechnology company focused on discovering, developing, and delivering novel high-quality medicines for people living with rare metabolic diseases, has reported an insider sell according to a recent SEC filing.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles